- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
Recent News
Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins
Mar 2nd, 2018
Data on cytokeratin-18 (K-18) and enhanced liver fibrosis (ELF) score in insulin-treated diabetes patients with non-alcoholic fatty liver disease (NAFLD) are limited. This study analyzed phase III data comparing basal insulin […]
Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients
Mar 2nd, 2018
There has been a widespread misconception among physicians that African Americans are protected from developing nonalcoholic steatohepatitis (NASH). However, a formal histologic and metabolic comparison against well-matched Caucasians has […]
New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
Mar 2nd, 2018
This study aimed to analyze adult kidney transplant recipients (KTRs) for the risk of new-onset diabetes after transplantation (NODAT) associated with viral serologies and immunosuppression regimens [tacrolimus (Tac) + mycophenolate (MPA), […]
ECHO Type 1 Diabetes
ECHO Type 1 Diabetes is an 18-month pilot program, which is allowing researchers at the University of Florida and Stanford University to learn more about how to improve care access for underserved adult and pediatric communities living with Type 1 Diabetes (T1D).